omalizumab
Selected indexed studies
- Omalizumab safety concerns. (J Allergy Clin Immunol, 2025) [PMID:39542143]
- A practical guide for implementing omalizumab therapy for food allergy. (J Allergy Clin Immunol, 2024) [PMID:38599291]
- Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence. (Clin Rev Allergy Immunol, 2020) [PMID:32418171]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Omalizumab safety concerns. (2025) pubmed
- A practical guide for implementing omalizumab therapy for food allergy. (2024) pubmed
- Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence. (2020) pubmed
- Omalizumab for food allergy. (2025) pubmed
- Omalizumab and other biologics in drug desensitization. (2020) pubmed
- Omalizumab for atopic dermatitis: evidence for and against its use. (2019) pubmed
- Update on omalizumab in allergen immunotherapy. (2021) pubmed
- Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis. (2024) pubmed
- Roles of omalizumab in various allergic diseases. (2020) pubmed
- Combination of omalizumab with allergen immunotherapy versus immunotherapy alone for allergic diseases: A meta-analysis of randomized controlled trials. (2024) pubmed